Emeritus Medical Technology and PathMD Announce Strategic Partnership

The Partnership Will Enable Emeritus Medical Technology to Expand Testing Capabilities and Geographic Reach

LAKE FOREST, Calif., Feb. 14, 2025 /PRNewswire-PRWeb/ -- Emeritus Medical Technology, a rapidly growing cancer diagnostics and information company and PathMD, a state-of-the-art CLIA/CAP-accredited laboratory with a decade-long history of providing best-in-class service, are pleased to announce a strategic partnership aimed at enhancing testing services and expanding geographic reach. This collaboration will strengthen both organizations' capabilities in providing high-quality diagnostic services while maintaining the turnaround time and service excellence their clients have come to rely on.

Through this partnership, Emeritus Medical Technology will expand its market-leading services under the EmeritusDX, Freedom Pathology, PathMD, and Specialized University Pathologists brands. In addition, this agreement will enable Emeritus Medical Technology to broaden its presence in California and accelerate the introduction of Epidermal Nerve Fiber Density (ENFD) testing to the market.

"Our partnership with Emeritus Medical Technology represents a significant step in expanding our testing portfolio for existing clients," said Robert Phillips, CEO of PathMD. "By working together, we can offer a broader range of services while maintaining the fast turnaround times and high level of service that our clients depend on."

Robert Embree, CEO of Emeritus Medical Technology, emphasized the strategic value of the partnership, stating, "This agreement allows us to strengthen our presence in California while expediting the introduction of ENFD testing to the market. We are excited to collaborate with PathMD and leverage our combined expertise to provide market-leading diagnostic solutions."

This partnership underscores the commitment of both companies to innovation, service excellence, and expanding access to advanced diagnostic testing. Clients can expect a seamless transition and an enhanced portfolio of high-quality diagnostic services as a result of this collaboration.

Haverford Healthcare Advisors provided transaction advisory services to Path MD, Inc. in connection with the transaction.

About EmeritusDX

EmeritusDX is a cancer diagnostic and information company. Our expertise is in delivering actionable clinical information. Within our world-class laboratory, we perform testing that guides the diagnosis and treatment of cancer patients. Our partners include hospital and private pathology laboratories, biotechnology companies, academic institutions, contract research and pharmaceutical development organizations, and more. We understand the dependency on our accurate and timely results and our commitment to excellence in this regard is unwavering.

About PathMD

PathMD is a state-of-the-art CLIA/CAP-accredited laboratory with over a decade of experience in anatomic and molecular testing. Located in Los Angeles, California, PathMD provides comprehensive pathology and clinical testing services across multiple specialties, including gastroenterology, women's health, urology, orthopedics, podiatry, and dermatology. Committed to innovation and integrity, PathMD delivers precise and reliable diagnostic solutions to support healthcare providers and their patients.

please call 800-959-2846 or email [email protected]

Media Contact

Charles Caymus, Emeritus Medical Technology, LLC, 1 800-959-2846, [email protected], www.emeritusdx.com 

View original content to download multimedia:https://www.prweb.com/releases/emeritus-medical-technology-and-pathmd-announce-strategic-partnership-302376759.html

SOURCE Emeritus Medical Technology, LLC